Scope Ophthalmics launched tranquileyes™ ‘moist heat’ treatment for ocular surface diseases at 100% Optical
Scope Ophthalmics, a leading player in the UK ocular surface disease market made its debut at the trade show, 100% Optical - 7 to 9 February - and launched the Tranquileyes™ innovation for dry eye disease management.
Using specially-designed goggles, warm water and reusable gel pack technology, this first-of-its-kind treatment enables patients to create a safe, soothing, moist-heat compress; an alternative to dry heat products. Moist heat loosens the oils in the meibomian glands, penetrating deeply to help hydrate the eyelid and surrounding skin, and promote circulation. By contrast, dry heat pulls moisture away from the eyelid and the sensitive surrounding skin, negating the anti-aging requirements of many women, and increasing the instability of the tear film. Studies1 have shown that applying effective moist heat to the eyelids is beneficial for all levels of meibomian gland dysfunction (MGD). Tranquileyes™ is available as 3 products: Instants (ideal for travelling / out of home use), Beads (ideal for home use) and Advanced (a hybrid of both).
Tom Freyne, Commercial Director at Scope Ophthalmics explains, “We’re very excited to be at 100% Optical for the first time, and to launch Tranquileyes™ which will provide eye care practitioners with a more sophisticated way to help people affected in the UK to manage their dry eye or MGD. This is a growing market as our population ages, so it’s important to be able to offer a good range of choice in terms of safe and effective innovations.”
Dry Eye Disease (DED) can affect people of any age, although risk increases with age. It is estimated that up to one in every three people over the age of 65 experiences problems with dry eyes, according to NHS Choices2. MGD is thought to be the leading cause of dry eye disease; a chronic disease, it is usually caused by obstruction of the secretory meibomian glands. The subsequent reduction of gland secretion results in a decreased amount of lipids in the tear film. This results in faster evaporation of the tear film and thus an evaporative dry eye. MGD alone is responsible for about 60% of all cases, in combination with aqueous deficiency for a further 20% of dry eyes3.